Patient basic information Patient: Ms. Aya (Aya Johnson) Nationality: Norway Diagnosis: Uterine Myeloma Diagnostic Hospital: H0H treatment: Organ transplant + anti-rejection treatment: 72 days of hospitalization Treatment cost: about 77528 yuan Treatment effect: Quality of life improvement Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, guidance, and on-site services throughout the treatment process. The MDT team used a comprehensive system of organ transplantation + anti-rejection therapy, and during the treatment the medical team closely monitored the patient's indicators, dynamic adjustment programs.
The care team provided 24-hour specialized care to ensure that patients received consistent and standardised medical care throughout the hospital. After 72 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. The treatment effect ultimately improved the patient's quality of life.
When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through the remote follow-up system. 'Mrs. Liu Aya, experts have criticized the case as a typical case of cross-border suspected seriousness clinical cases.
Liu4 is based on a multidisciplinary collaborative mechanism that developed organ transplant + anti-rejection treatment for uterine myeloma, reflecting the comprehensive strength of Chinese hospitals in the field of suspected disease diagnosis, and a summary of how international medical services are regulated. (Figure from Liu5 official news reports and medical scenarios)